Reuters logo
BRIEF-U.S. Patent and Trademark Office issues immunotehrapy patent to Adma Biologics
July 31, 2017 / 8:57 PM / 5 months ago

BRIEF-U.S. Patent and Trademark Office issues immunotehrapy patent to Adma Biologics

July 31 (Reuters) - Adma Biologics Inc-

* Adma Biologics - U.S. Patent and trademark office has issued to co U.S. Patent no. 9,714,283 which encompasses methods of providing immunotherapy to patients

* Adma Biologics Inc - the term of this newly issued patent extends to January 2035 Source text: (bit.ly/2hhz1lD) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below